Objective: The effect of a diet rich in monounsaturated fatty acids (MUFA) on blood pressure, glycemic control, lipids and insulin sensitivity was evaluated in women with gestational diabetes mellitus. Design and methods: A randomized, unpaired diet intervention was performed in 27 women with gestational diabetes mellitus in an outpatient clinic. After randomization the women received either a high-carbohydrate diet (H-CHO) or a high-MUFA diet (H-MUFA) from the 33rd gestational week of pregnancy. Outcome measures were 24 h ambulatory blood pressure, blood lipids, glycemic control and insulin sensitivity estimated by an intravenous glucose tolerance test. Results: The 24 h diastolic blood pressure increased more in the H-CHO group than in the H-MUFA group (P`0.04). Conclusions: After 5 weeks of treatment with a MUFA-enriched diet, no increase in 24 h diastolic blood pressure and no adverse effects on blood lipids were seen. The favorable effect on the blood pressure by the MUFA diet is a possible non-medication treatment. The H-MUFA diet had no advantage to the H-CHO diet in ameliorating the decline of insulin sensitivity in third term of pregnancy in GDM.
Introduction
Gestational diabetes mellitus (GDM) occurs in 2 ± 4% of all pregnancies and is characterized by a pronounced decrease in insulin sensitivity and an insuf®cient insulin secretion leading to abnormal glucose tolerance during pregnancy (Hollingsworth, 1983; Buchanan et al, 1990; National Diabetes Data Group, 1979; American Diabetes Association, 1993; Ku Èhl, 1975; Ku Èhl et al, 1984) . The advantage of a high-carbohydrate, low-fat diet in treatment of type 2 diabetes has been questioned, due to carbohydrate-induced increase of triacylglycerol concentrations (American Diabetes Association, 1987; Medical Advisory Committee, 1982; Pedersen O, 1994; Coulston et al, 1987 Coulston et al, , 1988 . Studies on carbohydrate and lipid metabolism in patients with type 2 diabetes indicate that diets rich in monounsaturated fatty acids (MUFA) may safely be applied (Bonamone et al, 1991; Garg et al, l988, 1992a,b; Campell et al, 1994; Rasmussen et al, 1993) . In addition, the MUFA-enriched diet may have bene®cial effect on blood pressure (Rasmussen et al, 1993) . Consequently, a MUFA-rich diet may be a potential treatment in women with gestational diabetes mellitus (GDM), reducing the risk of malregulation of glucose and hypertension. In addition, pregnancy in the last trimester is characterized by increased levels of plasma fatty acids, cholesterol and triacylglycerol-rich lipoproteins, which a MUFA diet has improved in subjects with type 2 diabetes (Garg et al, l992a, b) .
The present study compared the effects of a MUFA-rich diet with the recommended high-carbohydrate diet on 24 h ambulatory blood pressure, glycemic control, blood lipids and insulin sensitivity in women with GDM.
Subjects and methods
Twenty-seven pregnant women participated in the study out of 36 women with a positive oral glucose tolerance test (OGTT) before the 34th gestational week during two consecutive years (Table 1) . Nine women did not participate due to their refusal (n 3), language problems (n 3), negligence (n 1), medical treatment (n 1) or due to alcoholism (n 1). In Denmark, screening for GDM is done with fasting glucose measurements of women with history of obesity, diabetes mellitus in relatives, previous GDM, birthweight b 4500 g, stillbirth, age above 38 y or current glucosuria. When two independent fasting capillary plasma glucose values are above 4.6 mmolal the woman is referred for a 3 h OGTT using 75 g glucose with blood samples taken every 30 min. GDM was de®ned as two or more plasma glucose samples above three standard deviations of the mean. Exclusion criteria were any hypoglycemic, anti-lipidemic or antihypertensive medication. Further measurements of fasting and postprandial glucose showed that insulin was not needed in the eligible woman, thus they were treated with diet alone. The local ethical committee approved the study, and all women gave their informed consent. After diagnosis the woman were instructed to follow a high-carbohydrate diet until the 34th week where the participants were randomized into two groups stratifying for prepregnant normal weight and obesity. They were from the 34th week treated with normo-and isocaloric diets containing either high carbohydrate (H-CHO) or high monounsaturated fatty acids (H-MUFA) during the last 7 weeks of the pregnancy.
Randomization was performed block-wise strati®ed for prepregnancy weight with an expected ratio of obese to normal weight of three to one. The block sizes were six and two in the two strata. The randomization was performed by a third person at an independent centre outside our institution, which produced information about the outcome of randomization at baseline measurement in week 33.
At entry of the 33rd, 36th and 38th gestational weeks, clinical and 24 h ambulatory blood pressure were determined and an intravenous glucose tolerance test was performed with infusion of 50% glucose solution (dose 300 mgakg) over 1 min. The infusion start was taken as time zero. Blood samples for measurements of plasma glucose and insulin concentrations were taken at time 0, 2, 3, 4, 5, 6, 8, 10, 14, 19, 30, 40, 60, 90, 120 and 180 min. The intravenous glucose tolerance index (Kg) was calculated as the slope of the logarithm of the plasma glucose concentrations from 10 to 40 min to allow the proper mixing of intravenous glucose from 0 to 10 min. The insulin sensitivity was estimated as formerly described (Galvin et al, 1992) . Shortly, the insulin sensitivity was calculated as (Kg) divided by the incremental area under curve of the plasma insulin concentrations from 0 to 40 min. This insulin sensitivity index has previously been evaluated against the euglycemic, hyperinsulinemic clamp technique and was found to perform best based on statistical criteria and time-saving compared with other measures of insulin sensitivity (S 1 ) from the IVGTT (Galvin et al, 1992; Anderson et al, 1995) . Acute insulin response to glucose (AIR glucose ) was calculated as the mean of the plasma insulin concentrations from 2 to 10 min above basal plasma insulin. Glucose assimilation index, a measure of insulin mediated glucose uptake, was calculated as AIRglucose ÂS 1 (Kahn et al, 1993) . To further evaluate any possible changes between the two groups, the delta changes over time were calculated, ie the mean of the intervention values minus the pre-intervention value ( Table 2) . One of the 27 women did not have an intravenous glucose tolerance test due to contractions, two other women only attended in weeks 33 and 38, and two other women attended in weeks 33 and 36 only and delivered in week 38. Fasting blood samples were taken to measure glucose, insulin, fructosamine, HbA lc , lipids and lipoproteins. The tables show data from all 27 women whenever they completed the testing. Ambulatory blood pressure was measured by means of a portable automatic monitor (SpaceLab 90207, Redmond, WA, USA) by oscillometry. The equipment was programmed for cuff insuf¯ation every 20 min from 06:00 to 24:00 h, every hour during the night and monitored on the non-dominant arm. The average of three oscillometric and auscultatory measurements is termed the clinical oscillometric and the clinical auscultatory blood pressures, respectively. The auscultatory measurements were recorded with a random zero sphygmomanometer (Hawskley, Lancing, UK).
A 24 h urine sample was collected concomitantly with the 24 h blood pressure measurement and analysed for albumin, glucose, sodium, potassium and creatinine. At entry in the study and during gestational week 37, the participants weighed and recorded their food for three working days and one weekend day to estimate the energy intake and composition. The food records were collected and coded by the dietitian and the nutrient content was calculated by a computer program (Dankost, 1980) . The dietitian discussed and assessed with photographs of similar portions and food replicas any cases of uncertainty in food records. All foods were coded for analysis in the database. The nutrient composition is given in Table 3 . The total daily energy intake averaged 8000 kJ. The MUFA source in the H-MUFA diet was a hybrid sun¯ower oil with a high content of oleic acid (80%). Snacks in accordance with the diet scheme were given as almonds and hazelnuts. Bread, potato and rice enriched the H-CHO diet. Apart from the diet, the women continued their habitual eating pattern and activities of daily living. The participants visited the dietitian every week and were weighed without shoes, jackets and sweaters. Their diet scheme was reviewed and the energy intake adjusted if body weight differed by more than 500 g from the planned weight.
Plasma and urinary glucose concentrations were measured by a glucose oxidase method. Serum insulin concentrations were determined by radioimmunoassay (érskov et al, 1968) . HbA lc was measured by a commercial kit (BioRad, Richmond, CA, USA; normal range: 4.4 ± 6.4%). Triacylglycerols and lipoproteins were measured on a Enichom Chem 1 analyser and fructosamine by microdetermination (Boye et al, 1988) .
The results are expressed as mean AE s.e.m. unless otherwise stated. Multiple comparisons between the groups were made by two-way analysis of variance (ANOVA, SOLO software, distributed by BMDP Statistical Software, Berkeley, CA, USA). The post-hoc testing after signi®cance was done with Newman±Keuls' test. Data were transformed by taking the logarithm if the data did not follow normal distribution.
Body mass index (BMI) was found to be the only variable of signi®cance as possible confounder. The difference from the 33rd to 38th week was adjusted for BMI by regression analysis with BMI and group as the dependent variables.
Testing between groups was done with the unpaired Student's t-test if data followed normal distribution, otherwise the Mann ± Whitney test was applied. Testing for normality was done with the Kolmogorow ± Smirnoff test. P`0.05 was considered statistically signi®cant. The sample size was 10 in each treatment group with a power of 80 and an alpha of 0.05 as calculated from a difference in mean cholesterol of 0.65 mmolal and standard deviation of 0.73 (Garg et al, 1992b) .
Results
The 27 included women had a stable body weight with a weight loss averaging 0.3 kg (range 74 ± 4 kg) on the H-CHO diet vs 0.1 kg (range 73 ± 6 kg) on the H-MUFA diet. The BMI before delivery was 32.2 AE 1.7 and 35.5 AE 2.2 kgam 2 in the H-CHO and H-MUFA group, respectively. The concentrations of fructosamine, HbA lc , postprandial glucose, sodium and potassium, the creatinine clearance and albumin excretion rate were similar before and changed similarly during the two diet periods (Table 1) . Albumin excretion rate increased in both diet groups following intervention (P`0.05, ANOVA). Similar blood lipids were seen in response to the two diets.
No difference was found between the groups at any time point in fasting glucose and insulin concentrations before and following intervention (Table 2) . However, the GDM women were not perfectly matched regarding the preintervention insulin sensitivity, AIR glucose and glucose assimilation index. Thus, at all time points glucose assimilation index was signi®cantly increased in the H-CHO group compared to the H-MUFA group. Applying two-way ANOVA, no difference between the two diets could be demonstrated in the changes from baseline throughout pregnancy in fasting glucose, insulin (Kg), insulin sensitivity, AIR glucose and assimilation index. No change could be demonstrated in any IVGTT parameters obtained from weeks 36 ± 38 in the H-MUFA group. In the H-CHO group fasting insulin concentration decreased and the Kg-value increased. Thus, the means of the IVGTT parameters obtained at weeks 36 and 38 were calculated and used as a measure of the intervention effect. In the H-CHO group fasting insulin concentration declined whereas in the H-MUFA group no change could be demonstrated. In both groups the glucose assimilation index increased, which was re¯ected in a non-signi®cant decrease in fasting plasma glucose concentration in both groups. Moreover, in the H-MUFA group, but not in the H-CHO group, the AIR glucose increased which, however, was not re¯ected in a decreased in the Kg value in the H-MUFA group.
A signi®cant difference in the intervention effect on insulin sensitivity was observed in the delta changes between the two groups with the H-CHO group increasing 15% in insulin sensitivity compared to the 34% decrease in the H-MUFA group (Table 2 ). Figure 1 shows the insulin sensitivity index vs the AIR glucose before and following intervention. The H-MUFA group is located below and to the left of the H-CHO group, most pronounced following intervention ( Figure 1B ). This is re¯ected in the signi®-cantly decreased glucose assimilation index in the H-MUFA group at all time points.
The two groups had similar intake at entry in week 33 and reported different intake in MUFA, fat and carbohydrate in week 37 (Table 3) . The H-MUFA group increased their MUFA and total fat intake and consequently their carbohydrate and protein intake decreased. The fatty acid distribution in serum in the H-MUFA group showed an increase in the ratios MUFAaSFA (0.81 AE 0.03 to 0.92 AE 0.03, weeks 33 ± 38, P`0.02) and MUFAaPUFA (1.10 AE 0.07 to 1.32 AE 0.07, weeks 33 ± 38, P`0.001).
The oscillometric diastolic blood pressure in the women on the H-CHO diet increased in comparison to the H-MUFA diet group. The effect of the H-CHO diet on blood pressure was present both during day-and night-time but did not reach the level of signi®cance when the measurements were analysed separately (Table 4) . Analysis by one-way ANOVA showed that only the H-CHO group increased signi®cantly in the oscillometric blood pressure in the 24 h, day-and night-time measurements (Table 4) .
Both the pre-intervention mean diurnal diastolic (Spearman's rho, r 0.44, P`0.03) and systolic (r 0.44, P`0.03) blood pressures were positively associated with the fasting plasma insulin concentration in the combined group (Figure 2) , whereas no correlation with insulin sensitivity could be demonstrated. Moreover, at no other time points did fasting plasma insulin concentration or insulin sensitivity correlate to blood pressure (data not shown).
Neonatal birth weight was similar in the two groups (3743 AE 602 vs 3742 AE 501 g, H-MUFA and H-CHO, respectively, mean AE s.d.). Birth weight in both groups was heavier compared to the expected birthweight in the background population (3294 AE 250 g, mean AE s.d. of 4742 births at the same clinic during the same period).
Discussion
In the present study an increase of blood pressure was found in the H-CHO group only. Assuming no inherent diet effect on heart rate, the similar decrease of ambulatory heart rate during the two periods (Table 4) indicates that the unchanged blood pressure during the H-MUFA diet treatment period could not be ascribed to difference in physical activity.
The unchanged blood pressure (BP) during the H-MUFA diet as compared to the increase in the H-CHO Figure 1 Insulin sensitivity (S i ) versus insulin secretion (AIR glucose ) before intervention (A) and following intervention (B) in GDM women treated with an H-CHO diet or an H-MUFA diet. The ®gure illustrates the decreased insulin secretion for the given insulin sensitivity (glucose assimilation index or insulin-mediated glucose disposal) in the women treated with the H-MUFA diet both before and following intervention, ie they are located lower and to the left compared to the H-CHO diet group. group, was apparently not due to weight loss or reduction in the sodium or potassium intake since weight changes and the 24 h urinary excretion of these electrolytes was similar in the two groups.
Thus, unchanging diurnal blood pressure may be caused by the H-MUFA diet in itself. Similar ®ndings have been demonstrated in normotensive patients with type 2 diabetes after 3 weeks of treatment when blood pressure decreased on a MUFA-rich diet (Rasmussen et al, 1993) . Also, lower diastolic blood pressure has been found in normotensive, non-diabetic subjects on a MUFA rich-diet compared to subjects on a diet rich in saturated fatty acid (Mutanen et al, 1992) . Moreover, recent studies have demonstrated that an increase in the amount of saturated fat content in middleaged men normally living on a MUFA-rich diet was associated with an increase in systolic blood pressure (Mutanen et al, 1992) . It has been suggested that the bene®cial effect of oleic acid on blood pressure might be secondary to an improvement in insulin sensitivity, which was inversely correlated to blood pressure under different clinical conditions (Dosdon, 1991; DeFronzo et al, 1991; Julius et al, 1991; Strazzullo et al, 1986) . Although we ®nd a positive association between BP and fasting insulin concentration, the mechanism behind the blood pressure lowering effect of MUFA seems not to be mediated via an improvement in insulin sensitivity or decrease of hyperinsulinemia as the MUFA diet was not associated with an improvement of insulin sensitivity. Thus, the mechanism behind the blood pressure reduction remains unknown.
No difference was found in overall glycemic control between the H-MUFA and the H-CHO group. This may be explained by the fact that the HbA lc concentrations were already within normal range in both groups, which may have blunted an effect of either the two diet regimens. In accordance, Bonanome found neither improved glucose homeostasis nor changes in lipoprotein concentrations after a 2 month intervention with high-MUFA diet vs high-carbohydrate diet in well-controlled patients with type 2 diabetes (Bonamone et al, 1991) . However, in the present study, it seems as the insulin sensitivity improved in the H-CHO group whereas in the H-MUFA it did not. In the H-MUFA group the AIR glucose increased as a re¯ection of the decline in insulin sensitivity. However, an H-CHO diet is shown to have detrimental effect in patients with type 2 diabetes with increasing glucose intolerance (Parillo et al, 1996) . The slightly favorable baseline values in the H-CHO group may have helped to evade this effect.
Although body weight was not signi®cant different between the intervention groups, we cannot rule out a confounding effect that statistical adjustment cannot compensate for. However, biological variation is the most likely explanation for the ®ndings in the IVGTT data due to the limited number of subjects and size and variation of the effects with a consequently high risk of type 2 error. This does not apply to blood pressure data as the results run contrary to the expected rise in the H-MUFA group with a magnitude and variation that gives a power of more than 95 with an alpha of 0.05. Adding to this point is slightly unfavorable baseline values of the H-MUFA group which showed higher BP, HbA lc , glucose and Kg, although all were statistically insigni®cant. The H-MUFA diet had no advantage over the H-CHO diet in ameliorating the decline of insulin sensitivity in third term of pregnancy in GDM.
We found similar in¯uence of a MUFA-rich diet compared to a CHO-rich diet on cholesterol and lipoprotein metabolism. This result corresponds to previous data from patients with type 2 diabetes (Bonamone et al, 1991; Campell et al, 1994; Rasmussen et al, 1993) . In contrast, Garg et al found improved lipoprotein composition after a H-MUFA diet compared to a H-CHO diet in insulin-treated and orally drug-treated patients with type 2 diabetes (Garg et al, 1988 (Garg et al, , 1992a . However, the difference in CHOintake in the studies of Garg was large (30±35% of energy in formula diets) compared to the present study, which showed a self-reported difference in energy from CHO of 4% between the two diets.
The importance of dietary intervention in GDM patients is underlined by the change in energy requirements, decrease in physical activity accompanying the progression of pregnancy combined with a gradual metabolic decompensation. We found no weight change in our study with a high-fat diet. Nevertheless, the diet records exhibited a 20 ± 30% underestimation of the energy intake. Compliance to the diet was con®rmed as the percentage of MUFA increased in the blood samples drawn.
In summary, the present data demonstrate that in pregnancy complicated by GDM, a high-MUFA diet may prevent the expected rise in blood pressure without exerting adverse effects on lipid and lipoprotein concentrations. However, this was not mediated via changes in insulin sensitivity. The H-CHO diet had a possible advantage over MUFA-enriched diet in ameliorating the decline of insulin sensitivity in third term of pregnancy. The therapeutic impact of these effects of a MUFA-rich diet needs to be established.
